Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.35 USD | +0.62% | -0.32% | -9.61% |
May. 24 | Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi | MT |
May. 09 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.61% | 1.79B | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- JMP Securities Adjusts Inhibrx Price Target to $27 From $35, Maintains Market Outperform Rating